Description
Dengue virus (DV) infections cause undisputedly the most important arthropod-borne viral disease in terms of worldwide prevalence, human suffering, and cost. Worldwide DV infection prevalence in 2010 was between 284 to 528 million cases. Approximately 84% of these cases come from Asia and the Americas, where the cost for emerging economies can be as high as 580 million dollars per year. Thus, the need for an efficient vaccine against DV is extreme.
Copyright Statement
Reuse Permissions
Details
Title
- Dengue Vaccines: Strongly Sought But Not a Reality Just Yet
Contributors
- Maria del Angel, Rosa (Author)
- Reyes del Valle, Jorge (Author)
- College of Liberal Arts and Sciences (Contributor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2013-10-03
Resource Type
Collections this item is in
Identifier
- Digital object identifier: 10.1371/journal.ppat.1003551
- Identifier TypeInternational standard serial numberIdentifier Value1553-7366
- Identifier TypeInternational standard serial numberIdentifier Value1553-7374
Note
- The article is published at http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1003551, opens in a new window
Citation and reuse
Cite this item
This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.
Angel, R. M., & Valle, J. R. (2013). Dengue Vaccines: Strongly Sought but Not a Reality Just Yet. PLoS Pathogens, 9(10). doi:10.1371/journal.ppat.1003551